Backed by over 85 years of experience in parenterals, Baxter’s BioPharma Solutions (BPS) business collaborates with pharmaceutical companies to support commercialization objectives for their molecules. BPS is a premier CMO with a focus on specialized sterile injectable manufacturing designed to meet complex and traditional sterile challenges. 

Our state-of-the-art, award-winning facilities have primary locations in: 
-Bloomington, Indiana, USA facility is a leader in sterile contract manufacturing and offers form/fill/finish services and solutions for injectables designed to meet traditional sterile manufacturing challenges.
-Halle/Westfalen, Germany facility has over 60 years of experience and is recognized as a world-class manufacturer of oncology products and other sophisticated compounds.

BPS can support your pharmaceutical needs with a broad portfolio of sterile fill/finish production capabilities, and our reputation is built on the high-quality products we manufacture for our clients in a cGMP environment. Our delivery systems include: prefilled syringes, liquid/lyophilized vials, diluents for reconstitution, cartridges, powder-filled vials, and sterile crystallization. Our drug categories include: small molecules, biologics, vaccines, cytotoxics, highly potent compounds, and ADCs (antibody-drug conjugates). From formulation and development, through commercial launch, our extensive, customized support services can guide you through marketplace complexities, helping you achieve the full potential for your drug molecule. Whether you face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, risk mitigation concerns, or patent expiry challenges, we offer tailored and versatile solutions to help achieve your commercialization objectives. 

Related Categories

Sales Markets

Western Europe; Eastern Europe; Asia; North America